The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
NCT00195741
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine
Interventions
DRUG:
divalproex sodium
Sponsor
Abbott